Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bronchodilatory Effect of Formoterol/Mometasone pMDI in Children with Asthma
NCT00746330Phase 2Completed
- Sponsor
- Novartis
- Start
- Aug 2008
- Primary completion
- Apr 2009
- Modality
- Orthosteric Ligands
- Countries
- 3
01
Overview
A Phase 2 trial of mometasone furoate + formoterol fumarate in asthma, sponsored by Novartis. Started Aug 2008; status: completed.
02
Drugs
mometasone furoate + formoterol fumarate
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00746330.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00746330.